Company Filing History:
Years Active: 2004
Title: Ralph Dittrich: Innovator in Pharmaceutical Preparations
Introduction
Ralph Dittrich is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for side effects associated with GnRHa therapy. His innovative work has led to the creation of effective pharmaceutical preparations that address various side effects experienced by patients undergoing this type of therapy.
Latest Patents
Ralph Dittrich holds a patent for "Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy." This patent focuses on pharmaceutical preparations that contain effective amounts of chemically modified derivatives of 17α-estradiol, 17β-estradiol, and estriol. These preparations are designed to alleviate side effects such as hot flashes, prostate enlargement, and gynecomastia. Notably, the patent highlights the use of 14α, 15α-methylene-1,3,5(10),8-tetraene-3,17α-diol as a particularly preferred compound.
Career Highlights
Ralph Dittrich is associated with Jenapharm GmbH & Co. KG, where he has been instrumental in advancing pharmaceutical innovations. His work has not only contributed to the company's reputation but has also positively impacted patient care in the field of hormone therapy.
Collaborations
Ralph Dittrich has collaborated with esteemed colleagues, including Mcihael Oettel and Ludwig Wildt. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective pharmaceutical solutions.
Conclusion
Ralph Dittrich's contributions to pharmaceutical preparations for treating side effects during GnRHa therapy exemplify his commitment to improving patient outcomes. His innovative spirit and collaborative efforts continue to make a significant impact in the field of medicine.